[go: up one dir, main page]

MX9702666A - Nuevos peptidos con efectos inmunoreguladores. - Google Patents

Nuevos peptidos con efectos inmunoreguladores.

Info

Publication number
MX9702666A
MX9702666A MX9702666A MX9702666A MX9702666A MX 9702666 A MX9702666 A MX 9702666A MX 9702666 A MX9702666 A MX 9702666A MX 9702666 A MX9702666 A MX 9702666A MX 9702666 A MX9702666 A MX 9702666A
Authority
MX
Mexico
Prior art keywords
new peptides
immunomodulatory effects
peptides
new
immunomodulatory
Prior art date
Application number
MX9702666A
Other languages
English (en)
Other versions
MXPA97002666A (es
Inventor
Hakan Bergstrand
Tomas Eriksson
Kostas Karabelas
Magnus Lindvall
Bengt Sarnstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MXPA97002666A publication Critical patent/MXPA97002666A/es
Publication of MX9702666A publication Critical patent/MX9702666A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nuevos péptidos de acuerdo con la formula (I), A-X-Y-Cys-Z-B, un proceso para la preparacion y su uso en la fabricacion de preparaciones farmacéuticas. Los péptidos nuevos son excelentes como inmunoregulares.
MX9702666A 1994-10-14 1995-10-06 Nuevos peptidos con efectos inmunoreguladores. MX9702666A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides
SE9403526.8 1994-10-14
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects

Publications (2)

Publication Number Publication Date
MXPA97002666A MXPA97002666A (es) 1997-06-01
MX9702666A true MX9702666A (es) 1997-06-28

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702666A MX9702666A (es) 1994-10-14 1995-10-06 Nuevos peptidos con efectos inmunoreguladores.

Country Status (20)

Country Link
US (2) US6103697A (es)
EP (1) EP0783519A1 (es)
JP (1) JPH10507448A (es)
AU (1) AU705364B2 (es)
BR (1) BR9509345A (es)
CA (1) CA2201479A1 (es)
CZ (1) CZ111997A3 (es)
EE (1) EE9700087A (es)
FI (1) FI971499A7 (es)
HU (1) HUT77118A (es)
IL (1) IL115509A0 (es)
IS (1) IS4459A (es)
MX (1) MX9702666A (es)
NO (1) NO971625L (es)
PL (1) PL319631A1 (es)
SE (1) SE9403526D0 (es)
SK (1) SK46797A3 (es)
TR (1) TR199501255A2 (es)
WO (1) WO1996011943A1 (es)
ZA (1) ZA958140B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects
AU761083B2 (en) * 1998-06-03 2003-05-29 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
EP1948782B8 (en) 2005-04-25 2012-09-12 Cadila Pharmaceuticals Limited Vaccine adjuvants
KR101363455B1 (ko) 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
EP0300031A4 (en) 1987-01-28 1990-05-14 Ortho Pharma Corp IMMUNODEPRESSANT PEPTIDES AND METHODS OF USE THEREOF.
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
EP0341603A3 (en) * 1988-05-09 1990-07-04 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
KR100274321B1 (ko) 1990-09-11 2000-12-15 스미드 이. 그레이엄 데르마토파고이디즈(집 먼지 진드기)의 알레르기 항원의 클로닝 및 서열결정
WO1993000108A1 (en) * 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
HU220462B1 (hu) 1991-10-16 2002-02-28 Immulogic Pharmaceutical Corp. A Dermatophagoides nemzetség allergénjéből származó peptidek, ezeket tartalmazó gyógyszerkészítmények és eljárás házi poratka-érzékenység kimutatására
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
WO1994020127A1 (en) 1993-03-05 1994-09-15 Cytel Corporation Hla-a2.1 binding peptides and their uses
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
EP1013764A1 (en) 1994-07-05 2000-06-28 Steeno Research Group A/S Immunomodulators
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
ZA958140B (en) 1997-06-27
US6103697A (en) 2000-08-15
BR9509345A (pt) 1997-11-25
IL115509A0 (en) 1996-05-14
JPH10507448A (ja) 1998-07-21
NO971625D0 (no) 1997-04-09
US6228374B1 (en) 2001-05-08
FI971499A0 (fi) 1997-04-10
PL319631A1 (en) 1997-08-18
HUT77118A (hu) 1998-03-02
FI971499L (fi) 1997-06-10
FI971499A7 (fi) 1997-06-10
WO1996011943A1 (en) 1996-04-25
AU705364B2 (en) 1999-05-20
EP0783519A1 (en) 1997-07-16
AU3713395A (en) 1996-05-06
CZ111997A3 (en) 1997-12-17
SK46797A3 (en) 1997-09-10
CA2201479A1 (en) 1996-04-25
TR199501255A2 (tr) 1996-06-21
NO971625L (no) 1997-05-30
SE9403526D0 (sv) 1994-10-14
EE9700087A (et) 1997-10-15
IS4459A (is) 1997-04-08

Similar Documents

Publication Publication Date Title
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
ATE256138T1 (de) 9-oximsilyl erythromycin a derivate
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
ES552627A0 (es) Procedimiento para la preparacion de carbamatos de fenilo
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
FR2681326B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
ATE371670T1 (de) Reinigung von neurotrophinen
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
ATE233274T1 (de) Oxyiminopregnancarbolactone
FR2629825B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments
DZ1468A1 (fr) Composés nouveaux.
ES2039198T3 (es) Procedimiento para preparar 5-amino y 5-hidroxi-6,8-difluorquinolonas como agentes antibacteriales.
IT8647666A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
BG102623A (bg) Нови производни на бензоилгуанидина, методи за тяхното получаване и приложението им за производството на ле- карствени средства
MX9603092A (es) Nuevos compuestos con efecto analgesico y anestesico local.
MX9204613A (es) Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR005619A1 (es) Procedimiento para preparar compuestos dicetonicos
AR005704A1 (es) Heteroariloxazolidinonas
ES2060944T3 (es) Derivados de 2,5,6,7-tetranor-4,8-inter-m-fenileno de pgi2 (prostaglandina i2).
ATE293635T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
IT8748235A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
ES2065565T3 (es) 1-alquil-, 1-alquenil- y 1-alquinil-aril-2-amino-1,3-propanodioles y compuestos afines, un procedimiento y compuestos intermedios para su preparacion y su uso como medicamentos.
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.